Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records. [electronic resource]
Producer: 20201211Description: 1179-1188 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Bevacizumab -- therapeutic use
- Choroidal Neovascularization -- drug therapy
- Cohort Studies
- Electronic Health Records -- statistics & numerical data
- Female
- Fluorescein Angiography
- Humans
- Intravitreal Injections
- Male
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Treatment Outcome
- United States
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.